Xilio Development Stock Alpha and Beta Analysis
| XLO Stock | USD 0.92 0.02 2.13% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Xilio Development. It also helps investors analyze the systematic and unsystematic risks associated with investing in Xilio Development over a specified time horizon. Remember, high Xilio Development's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Xilio Development's market risk premium analysis include:
Beta 0.23 | Alpha 0.31 | Risk 8.08 | Sharpe Ratio 0.0395 | Expected Return 0.32 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Xilio |
Xilio Development Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Xilio Development market risk premium is the additional return an investor will receive from holding Xilio Development long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Xilio Development. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Xilio Development's performance over market.| α | 0.31 | β | 0.23 |
Xilio Development expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Xilio Development's Buy-and-hold return. Our buy-and-hold chart shows how Xilio Development performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Xilio Development Market Price Analysis
Market price analysis indicators help investors to evaluate how Xilio Development stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Xilio Development shares will generate the highest return on investment. By understating and applying Xilio Development stock market price indicators, traders can identify Xilio Development position entry and exit signals to maximize returns.
Xilio Development Return and Market Media
The median price of Xilio Development for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 is 0.82 with a coefficient of variation of 18.78. The daily time series for the period is distributed with a sample standard deviation of 0.17, arithmetic mean of 0.9, and mean deviation of 0.13. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acquisition by Russo Rene of 474000 shares of Xilio Development at 1.08 subject to Rule 16b-3 | 09/10/2024 |
2 | Xilio Therapeutics faces Nasdaq delisting over share price - Investing.com | 09/13/2024 |
3 | Disposition of 7186489 shares by Flynn James E of Xilio Development subject to Rule 16b-3 | 09/27/2024 |
4 | Acquisition by Kevin Brennan of 26000 shares of Xilio Development at 0.75 subject to Rule 16b-3 | 10/01/2024 |
5 | Xilio Therapeutics Announces Inducement Grants UnderNasdaq Listing Rule 5635 | 10/02/2024 |
6 | Xilio Therapeutics Announces Upcoming Poster Presentation at the Society for Immunotherapy of Cancer th Annual Meeting | 10/04/2024 |
7 | Acquisition by Huber Martin H. Jr. of 65000 shares of Xilio Development at 12.66 subject to Rule 16b-3 | 10/18/2024 |
8 | Companies Like Xilio Therapeutics Are In A Position To Invest In Growth | 10/25/2024 |
9 | Xilio Therapeutics Announces Initial Clinical Trial Data from Phase 1C Dose Escalation for Vilastobart , a Tumor-Activated Anti-CTLA-4, in Combination with Atez... | 11/07/2024 |
About Xilio Development Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Xilio or other stocks. Alpha measures the amount that position in Xilio Development has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Xilio Development Upcoming Company Events
As portrayed in its financial statements, the presentation of Xilio Development's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Xilio Development's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Xilio Development's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Xilio Development. Please utilize our Beneish M Score to check the likelihood of Xilio Development's management manipulating its earnings.
| 7th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 7th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Xilio Development
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Xilio Development Backtesting, Xilio Development Valuation, Xilio Development Correlation, Xilio Development Hype Analysis, Xilio Development Volatility, Xilio Development History and analyze Xilio Development Performance. To learn how to invest in Xilio Stock, please use our How to Invest in Xilio Development guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Xilio Development technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.